摘要:
The present invention provides a new ultra-long after-glow phosphorescent material and manufacturing method for the same. The said materials include a phosphor including aMS.bM3(PO4)2.cMSiO2.dMO.fAl2O3.xRO.yTR2O3.zMnO, where the M is Ca, Mg, Ba, Sr, Zn or combinations thereof, The R is Eu, Sm, Yb, Pr and Nd or combinations thereof; the TR is La, Y, Nd, Dy, Er, Tu, Ce, Ho or combinations thereof; and a, b, c, d, f x, y, z is the number of mol. The phosphorescent material has superior water resistance and temperature resistance.
摘要:
The present invention provides a new ultra-long after-glow phosphorescent material and manufacturing method for the same. The materials include a phosphor including aMS.bM3(PO4)2.cMSiO3.dMO.fAl2O3.xRO.yTR2O3.zMnO, where the M is Ca, Mg, Ba, Sr, Zn or combinations thereof; The R is Eu, Sm, Yb or combinations thereof; the TR is La, Pr, Y, Nd, Dy, Er, Tm, Ce, Ho or combinations thereof: and a, b, c, d, f, x, y, z is the number of mol. The phosphorescent material has superior water resistance and temperature resistance.
摘要:
Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
摘要:
FIG. 1 is a top, front and left side perspective view of a camera showing my new design; FIG. 2 is a front elevation view thereof; FIG. 3 is a rear elevation view thereof; FIG. 4 is a left side elevation view thereof; FIG. 5 is a right side elevation view thereof; FIG. 6 is a top plan view thereof; and, FIG. 7 is a bottom plan view thereof. The broken lines shown in the drawings are included for the purpose of illustrating portions of the camera that form no part of the claimed design.
摘要:
Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.
摘要:
Novel compounds of Formula (I) or pharmaceutically acceptable salts, prodrugs and biologically active metabolites thereof of Formula (I) wherein the substituents are as defined herein, which are useful as therapeutic agents.